{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:56:43Z","timestamp":1792598203394,"version":"4.5.0"},"reference-count":69,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd016401","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:31:53Z","timestamp":1792596713000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibiotic therapy for pelvic inflammatory disease: a network meta-analysis"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8331-2402","authenticated-orcid":false,"given":"Michail","family":"Papapanou","sequence":"additional","affiliation":[{"name":"Second Department of Obstetrics and Gynecology; Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens; Athens Greece"},{"name":"Cochrane Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9095-0007","authenticated-orcid":false,"given":"Melina","family":"Nikolakea","sequence":"additional","affiliation":[{"name":"School of Medicine; National and Kapodistrian University of Athens; Athens Greece"},{"name":"Cochrane Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9490-9973","authenticated-orcid":false,"given":"Ismini","family":"Tsakiri","sequence":"additional","affiliation":[{"name":"School of Medicine; National and Kapodistrian University of Athens; Athens Greece"},{"name":"Cochrane Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1822-6865","authenticated-orcid":false,"given":"Maria","family":"Toulaki","sequence":"additional","affiliation":[{"name":"School of Medicine; National and Kapodistrian University of Athens; Athens Greece"},{"name":"Cochrane Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Syristatidi","sequence":"additional","affiliation":[{"name":"School of Medicine, Dentistry and Nursing; University of Glasgow; Glasgow, Scotland UK"},{"name":"Cochrane Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-6623","authenticated-orcid":false,"given":"Charalampos S","family":"Siristatidis","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Unit, Second Department of Obstetrics and Gynaecology, Medical School; National and Kapodistrian University of Athens; Athens Greece"},{"name":"Cochrane Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2851-2011","authenticated-orcid":false,"given":"Patricia","family":"Ziegelmann","sequence":"additional","affiliation":[{"name":"Statistics; Federal University of Rio Grande do Sul (UFRGS); Porto Alegre Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4193-6919","authenticated-orcid":false,"given":"Jonathan","family":"Ross","sequence":"additional","affiliation":[{"name":"University of Birmingham; Birmingham UK"},{"name":"Birmingham City University; Birmingham UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2779-5443","authenticated-orcid":false,"given":"Ricardo F","family":"Savaris","sequence":"additional","affiliation":[{"name":"Ginecologia e Obstetricia; UFRGS-FAMED; Porto Alegre Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,21]]},"reference":[{"issue":"21","key":"10.1002\/14651858.CD016401-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/nejmra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD016401-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.mcna.2022.10.009","article-title":"Infectious vaginitis, cervicitis, and pelvic inflammatory disease","volume":"107","author":"Shroff","year":"2023","journal-title":"Medical Clinics of North America"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD016401-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1093\/infdis\/jiab116","article-title":"A review of the challenges and complexities in the diagnosis, etiology, epidemiology, and pathogenesis of pelvic inflammatory disease","volume":"224","author":"Hillier","year":"2021","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD016401-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1093\/infdis\/jiab031","article-title":"Pelvic inflammatory disease due to Neisseria gonorrhoeae and Chlamydia trachomatis: immune evasion mechanisms and pathogenic disease pathways","volume":"224","author":"Darville","year":"2021","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD016401-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/aog.0b013e3181e92c54","article-title":"Pelvic inflammatory disease","volume":"116","author":"Soper","year":"2010","journal-title":"Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD016401-BIB0006|cit6","unstructured":"World Health Organization (WHO) Women of reproductive age (15\u201349 years) population (thousands) Available at https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/women-of-reproductive-age-(15-49-years)-population-(thousands)"},{"issue":"1","key":"10.1002\/14651858.CD016401-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-023-16663-y","article-title":"Global burden of pelvic inflammatory disease and ectopic pregnancy from 1990 to 2019","volume":"23","author":"He","year":"2023","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1002\/14651858.CD016401-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.15585\/mmwr.mm6603a3","article-title":"Prevalence of pelvic inflammatory disease in sexually experienced women of reproductive age \u2212 United States, 2013-2014","volume":"66","author":"Kreisel","year":"2017","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"4","key":"10.1002\/14651858.CD016401-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR. Recommendations and Reports"},{"key":"10.1002\/14651858.CD016401-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.926351","article-title":"The severity of depression is associated with pelvic inflammatory diseases: a cross-sectional study of the United States National Health and Nutrition Examinations from 2013 to 2018","volume":"9","author":"Huang","year":"2022","journal-title":"Frontiers in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD016401-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s12906-025-05088-2","article-title":"Efficacy and security of oral Chinese patent medicine combined with antibiotics in the treatment of pelvic inflammatory disease: a Bayesian network meta-analysis","volume":"25","author":"Li","year":"2025","journal-title":"BMC Complementary Medicine and Therapies"},{"issue":"2","key":"10.1002\/14651858.CD016401-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1093\/cid\/ciae295","article-title":"Systematic review and meta-analysis of the association between Mycoplasma genitalium and pelvic inflammatory disease (PID)","volume":"82","author":"Htaik","year":"2024","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD016401-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1093\/clinids\/24.2.170","article-title":"Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients","volume":"24","author":"Arredondo","year":"1997","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD016401-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/01.aog.0000268801.90261.27","article-title":"Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease","volume":"110","author":"Savaris","year":"2007","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD016401-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/147323000303100108","article-title":"Efficacy and safety of azithromycin as monotherapy or combined with metronidazole compared with two standard multidrug regimens for the treatment of acute pelvic inflammatory disease","volume":"31","author":"Bevan","year":"2003","journal-title":"Journal of International Medical Research"},{"issue":"3","key":"10.1002\/14651858.CD016401-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/sextrans-2020-054468","article-title":"Treatment of mild-to-moderate pelvic inflammatory disease with a short-course azithromycin-based regimen versus ofloxacin plus metronidazole: results of a multicentre, randomised controlled trial","volume":"97","author":"Dean","year":"2020","journal-title":"Sexually Transmitted Infections"},{"issue":"12","key":"10.1002\/14651858.CD016401-BIB0017|cit17","first-page":"1006","article-title":"Azithromycin for PID beats doxycycline on all counts","volume":"56","author":"Rowland","year":"2007","journal-title":"Journal of Family Practice"},{"key":"10.1002\/14651858.CD016401-BIB0018|cit18","unstructured":"FDA Drug Label Available at https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=f9277bb8-982d-444d-9325-35d5c53a2d35"},{"issue":"5","key":"10.1002\/14651858.CD016401-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/aac.00243-22","article-title":"Impact of 16S rRNA single nucleotide polymorphisms on Mycoplasma genitalium organism load with doxycycline treatment","volume":"66","author":"Chua","year":"2022","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD016401-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1093\/cid\/ciac126","article-title":"Diagnosis and management of uncomplicated Chlamydia trachomatis infections in adolescents and adults: summary of evidence reviewed for the 2021 Centers for Disease Control and Prevention sexually transmitted infections treatment guidelines","volume":"74","author":"Geisler","year":"2022","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD016401-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jmb.2008.11.042","article-title":"Time-resolved binding of azithromycin to Escherichia coli ribosomes","volume":"385","author":"Petropoulos","year":"2009","journal-title":"Journal of Molecular Biology"},{"key":"10.1002\/14651858.CD016401-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0924-8579(01)00401-0","article-title":"Macrolides: structures and microbial targets","volume":"18","author":"Retsema","year":"2001","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"5","key":"10.1002\/14651858.CD016401-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.2165\/00003495-199244050-00007","article-title":"Azithromycin","volume":"44","author":"Peters","year":"1992","journal-title":"Drugs"},{"issue":"13","key":"10.1002\/14651858.CD016401-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/nejm199209243271304","article-title":"A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis","volume":"327","author":"Martin","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD016401-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1016\/0002-9343(91)90395-e","article-title":"Clinical microbiology of azithromycin","volume":"91","author":"Neu","year":"1991","journal-title":"American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD016401-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2165\/00003495-199651030-00013","article-title":"Azithromycin","volume":"51","author":"Dunn","year":"1996","journal-title":"Drugs"},{"issue":"2","key":"10.1002\/14651858.CD016401-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1097\/01.inf.0000112523.95762.f5","article-title":"Rationale for single and high dose treatment regimens with azithromycin","volume":"23","author":"Gordon","year":"2004","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"9","key":"10.1002\/14651858.CD016401-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s11095-011-0382-0","article-title":"Interdisciplinary science and the design of a single-dose antibiotic therapy","volume":"28","author":"Curatolo","year":"2011","journal-title":"Pharmaceutical Research"},{"issue":"6","key":"10.1002\/14651858.CD016401-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1097\/00007611-199306000-00002","article-title":"Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease","volume":"86","author":"Martens","year":"1993","journal-title":"Southern Medical Journal"},{"issue":"9","key":"10.1002\/14651858.CD016401-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD016401-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2165\/00003495-199958002-00012","article-title":"Quinolone activity against anaerobes","volume":"58","author":"Appelbaum","year":"1999","journal-title":"Drugs"},{"issue":"8","key":"10.1002\/14651858.CD016401-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/j.1469-0691.2008.02027.x","article-title":"Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis","volume":"14","author":"B\u00e9b\u00e9ar","year":"2008","journal-title":"Clinical Microbiology and Infection"},{"issue":"11","key":"10.1002\/14651858.CD016401-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/pds.5677","article-title":"Moxifloxacin monotherapy for treatment of uncomplicated pelvic inflammatory disease: a systematic review and meta-analysis with trial sequential analysis of randomized controlled trials","volume":"32","author":"Chen","year":"2023","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"7","key":"10.1002\/14651858.CD016401-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/cid\/ciaa101","article-title":"A randomized controlled trial of ceftriaxone and doxycycline, with or without metronidazole, for the treatment of acute pelvic inflammatory disease","volume":"72","author":"Wiesenfeld","year":"2020","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD016401-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/aac.00006-23","article-title":"In vitro susceptibility and resistance of mycoplasma genitalium to nitroimidazoles","volume":"67","author":"Wood","year":"2023","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD016401-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010285.pub3","article-title":"Antibiotic therapy for pelvic inflammatory disease","author":"Savaris","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD016401-BIB0037|cit37","doi-asserted-by":"crossref","unstructured":"Chaimani A Caldwell DM Li T Higgins JP Salanti G Chapter 11: Undertaking network meta-analyses (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch11"},{"key":"10.1002\/14651858.CD016401-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016401-BIB0039|cit39","unstructured":"Cumpston M Lasserson T Flemyng E Page MJ Chapter III: Reporting the review (chapter last updaed August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016401-BIB0040|cit40","unstructured":"Higgins JPT Lasserson T Thomas J Flemyng E Churchill R Standards for the conduct of new Cochrane Intervention Reviews. In: Higgins JPT, Lasserson T, Thomas J, Flemyng E, Churchill R. Methodological Expectations of Cochrane Intervention Reviews. Cochrane: London, August 2023 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals"},{"issue":"11","key":"10.1002\/14651858.CD016401-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/m14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD016401-BIB0042|cit42","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Thomas J Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis (last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016401-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch23"},{"key":"10.1002\/14651858.CD016401-BIB0044|cit44","doi-asserted-by":"crossref","unstructured":"Thomas J Petticrew M Noyes J Chandler J Rehfuess E Tugwell P Chapter 17: Intervention complexity (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch17"},{"key":"10.1002\/14651858.CD016401-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s13063-017-1978-4","article-title":"The COMET Handbook: version 1.0","volume":"18","author":"Williamson","year":"2017","journal-title":"Trials"},{"key":"10.1002\/14651858.CD016401-BIB0046|cit46","doi-asserted-by":"crossref","unstructured":"Peryer G Golder S Junqueira D Vohra S Loke YK Chapter 19: Adverse effects (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch19"},{"key":"10.1002\/14651858.CD016401-BIB0047|cit47","doi-asserted-by":"crossref","unstructured":"Li T Higgins JP Deeks JJ Chapter 5: Collecting data (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"key":"10.1002\/14651858.CD016401-BIB0048|cit48","doi-asserted-by":"crossref","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Chapter 9: Summarizing study characteristics and preparing for synthesis (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch9"},{"key":"10.1002\/14651858.CD016401-BIB0049|cit49","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies (last updated March 2025). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5.1. Cochrane, 2025 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016401-BIB0050|cit50","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Technical Supplement to Chapter 4: Searching for and selecting studies (last updated September 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD016401-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1355819619841647","article-title":"Development of the ACTIVE framework to describe stakeholder involvement in systematic reviews","volume":"24","author":"Pollock","year":"2019","journal-title":"Journal of Health Services Research & Policy"},{"key":"10.1002\/14651858.CD016401-BIB0052|cit52","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"key":"10.1002\/14651858.CD016401-BIB0053|cit53","unstructured":"Covidence Veritas Health Innovation 2026"},{"issue":"1","key":"10.1002\/14651858.CD016401-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41073-023-00130-8","article-title":"Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot","volume":"8","author":"Mol","year":"2023","journal-title":"Research Integrity and Peer Review"},{"key":"10.1002\/14651858.CD016401-BIB0055|cit55","unstructured":"Boutron I Page MJ Higgins JP Altman DG Lundh A Hr\u00f3bjartsson A Chapter 7: Considering bias and conflicts of interest among the included studies (last updated August 2022). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016401-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch8"},{"key":"10.1002\/14651858.CD016401-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016401-BIB0058|cit58","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect (last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016401-BIB0059|cit59","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016401-BIB0060|cit60","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses (last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD016401-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"e1003082","DOI":"10.1371\/journal.pmed.1003082","article-title":"CINeMA: an approach for assessing confidence in the results of a network meta-analysis","volume":"17","author":"Nikolakopoulou","year":"2020","journal-title":"PLOS Medicine"},{"issue":"414","key":"10.1002\/14651858.CD016401-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016401-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jrsm.1316","article-title":"A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses","volume":"10","author":"Langan","year":"2019","journal-title":"Research Synthesis Methods"},{"issue":"9","key":"10.1002\/14651858.CD016401-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"16","key":"10.1002\/14651858.CD016401-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1002\/sim.8158","article-title":"Network meta-analysis of rare events using the Mantel-Haenszel method","volume":"38","author":"Efthimiou","year":"2019","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD016401-BIB0066|cit66","unstructured":"Metreau E Young KE Eapen SG Understanding country income: World Bank Group income classifications for FY26 (July 1, 2025 \u2013 June 2026) https:\/\/blogs.worldbank.org\/en\/opendata\/understanding-country-income--world-bank-group-income-classifica"},{"issue":"2","key":"10.1002\/14651858.CD016401-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jacamr\/dlaf061","article-title":"Mitigating inequitable access to appropriate antibiotics in low- and middle-income countries","volume":"7","author":"Otaigbe","year":"2025","journal-title":"JAC-Antimicrobial Resistance"},{"issue":"1","key":"10.1002\/14651858.CD016401-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jclinepi.2013.08.005","article-title":"Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health","volume":"67","author":"O'Neill","year":"2014","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016401-BIB0069|cit69","unstructured":"Welch VA Petkovic J Jull J Hartling L Klassen T Kristjansson E Chapter 16: Equity and specific populations (last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from cochrane.org\/handbook"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:31:56Z","timestamp":1792596716000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD016401"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,21]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd016401","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,21]]}}}